Patents
Patents for C07D 405 - Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom (69,397)
07/2010
07/01/2010US20100168114 Invertebrate acetylcholinesterase inhibitors
07/01/2010US20100168107 Imidazole compounds for the treatment of neurodegenerative disorders
07/01/2010US20100168102 Amide Derivatives as Kinase Inhibitors
07/01/2010US20100168101 Oxindole hydrazide modulators of protein tyrosine phosphatases (ptps)
07/01/2010US20100168088 Pyrrolidine derivatives as nk-3 receptor antagonists
07/01/2010US20100168066 Novel insecticides
07/01/2010US20100168062 Quinoxaline Derivatives as Tyrosine Kinase Activity Inhibitors
07/01/2010US20100168052 Treatment of EBV and KHSV Infection and Associated Abnormal Cellular Proliferation
07/01/2010US20100167936 Use of ascorbic acid derivatives for the functionalization of matrices
07/01/2010US20100167924 Azolylmethyloxiranes, Their Use for Controlling Phytopathogenic Fungi and Compositions Comprising Them
07/01/2010US20100166765 Benzoquinazoline derivatives
07/01/2010US20100166706 Hcv ns-3 serine protease inhibitors
07/01/2010US20100163852 Material for light-emitting device and light-emitting device
07/01/2010CA2750841A1 Pyrimidine indole derivatives for treating cancer
07/01/2010CA2748251A1 Novel bicyclic heterocyclic compound
07/01/2010CA2748099A1 7-phenoxychroman carboxylic acid derivatives
07/01/2010CA2747925A1 Dihydropyridone amides as p2x7 modulators
07/01/2010CA2747863A1 Pyridazinone derivatives
07/01/2010CA2747795A1 Isoquinoline derivative
07/01/2010CA2747784A1 Pharmaceutical compounds
07/01/2010CA2745866A1 Dihydropyridone ureas as p2x7 modulators
07/01/2010CA2745865A1 Heterocyclic antiviral compounds
06/2010
06/30/2010EP2202231A1 2,3-dihydroiminoisoindole derivative
06/30/2010EP2202228A1 Amide compounds and use of the same
06/30/2010EP2200997A1 Synthesis of deuterated catechols and benzoýd¨ý1,3¨dioxoles and derivatives thereof
06/30/2010EP2200990A1 Gamma secretase modulators
06/30/2010EP2200436A1 Substituted pyrimidinyl-amines as protein kinase inhibitors
06/30/2010EP1476435B1 Novel pyridin- and pyrimidin-derivatives
06/30/2010EP1368323B1 Pyrimidine matrix metalloproteinase inhibitors
06/30/2010CN101765598A Fungicide N-5-membered fused heteroaryl-methylene-N-cycloalkyl-carboxamide derivatives
06/30/2010CN101765591A Pyrimidine derivatives useful for the treatment of inflammatory or allergic conditions
06/30/2010CN101765589A fungicide n-cycloalkyl-n-bicyclic-carboxamide derivatives
06/30/2010CN101759686A Synthesizing method and application of 2-substituted aryl-1-substituted benzyl benzimidazole compound
06/30/2010CN101759645A P38 inhibitors and methods of use thereof
06/29/2010US7745650 9,10-α,α-OH-taxane analogs and methods for production thereof
06/29/2010US7745645 Sulfonamide derivatives of xanthene compounds
06/29/2010US7745639 Dihydropyrazoles; anticarcinogenic agents can be synergistically combined with one or more active ingredients; side effect reduction
06/29/2010US7745638 Anticancer agents; such as 4-acetylamino-1H-pyrazole-3-carboxylic acid (4-fluoro-phenyl)-amide
06/29/2010US7745637 Peptide deformylase inhibitors
06/29/2010US7745481 Methods and compositions for the treatment and prevention of tumors, tumor-related disorders and cachexia
06/29/2010US7745465 Antiischemic agents; antiinflammatory agents; antiallergens; autoimmune disease
06/29/2010US7745462 5-[R-2-(1S,2S-2-Cyclohexylcyclopentylamino)-1-hydroxyethyl]-8-hydroxy-1H-quinolin-2-one, useful for treating conditions that are prevented or alleviated by activation of the adrenergic recptors
06/29/2010US7745460 LFA1 related immune and/or inflammatory disorders; interactions with leukointegrins; such as fused nitrogen heterocyclic secondary amine derivatives
06/29/2010US7745456 2,5-bis{[alkyl(or aryl)imino]aminophenyl}furans and thiophenes; "reversed" amidines; DNA-binding affinities; microbiocide; mycobacterial, fungal, protozoal infection; Mycobacterium tuberculosis, Trypanosoma spp., Candida albicans, Aspergillus spp., Cryptosporidium parvum, Giardia lamblia, Plasmodium spp.
06/29/2010US7745453 Hydroxypyrimidinone derivatives having inhibitory activity against HIV integrase
06/29/2010US7745442 Methods of reducing risk of infection from pathogens
06/29/2010US7745437 Compounds and compositions as protein kinase inhibitors
06/29/2010US7744838 Functionalized ionic liquids, and methods of use thereof
06/29/2010CA2557856C 3-'4-heterocyclyl-1,2,3,-triazol-1-yl!-n-aryl-benzamides as inhibitors of the cytokines production for the treatment of chronic inflammatory diseases
06/29/2010CA2345985C Substituted 1,3-diaryl-2-pyrid-2-yl-3-(pyrid-2-ylamino)propanol derivatives,processes for their preparation, pharmaceuticals comprising these compounds and their use
06/24/2010WO2010071750A1 Glucagon receptor antagonist compounds
06/24/2010WO2010069966A1 Substituted indazole derivatives active as kinase inhibitors
06/24/2010WO2010069879A1 Pyrrole derivatives for use as plant growth regulators
06/24/2010WO2010069833A1 Pyrimidin- 2 -ylamino derivatives and their use to treat inflammation
06/24/2010WO2010069593A1 Use of amphiphilic compounds for controlled crystallization of statins and statin intermediates
06/24/2010WO2010069502A2 Tetrazole substituted anthranilic acid amides as pesticides
06/24/2010WO2010069266A1 Heterocyclic nitrogenous or oxygenous compounds with insecticidal activity formed from dialdehydes and their preparation and uses thereof
06/24/2010WO2010069147A1 Dihydropyrimidine derivatives, compositions thereof and their use
06/24/2010US20100160636 Method for producing optically active amines
06/24/2010US20100160627 (2,3-cis)-3-amino-2-phenyl-2,3-dihydro-1,5-benzoxazepin-4(5H)-one; for treatment of neurological disorders related to amyloid beta protein production such as Alzheimer's disease; inhibit gamma secretase and thereby inhibit the production of amyloid beta protein
06/24/2010US20100160343 Heteroaryl, heterocyclic and aryl compounds which inhibit leukocyte adhesion mediated by vla-4
06/24/2010US20100160341 Heteroaryl, heterocyclic and aryl compounds which inhibit leukocyte adhesion mediated by vla-4
06/24/2010US20100160336 Azabicyclo (3.1.0) Hexane Derivatives Useful As Modulators Of Dopamine D3 Receptors
06/24/2010US20100160332 a2-Adrenoceptor Ligands
06/24/2010US20100160331 Novel carbamoyloxy arylalkan arylpiperazine compound, pharmaceutical compositions comprising the compound and method for treating pain, anxiety and depression by administering the compound
06/24/2010US20100160323 NOVEL PIPERAZINE DERIVATIVES AS INHIBITORS OF STEAROYL-CoA DESATURASE
06/24/2010US20100160322 Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases
06/24/2010US20100160318 3-Pyrrolo[b]Cyclohexylene-2-Dihydroindolinone Derivatives and Uses Thereof
06/24/2010US20100160306 Acylated Piperidine Derivatives as Melanocortin-4 Receptor Agonists
06/24/2010US20100160293 Solid Ophthalmic Drug for External Use
06/24/2010US20100160287 Compounds useful as inhibitors of janus kinases
06/24/2010CA2747035A1 Tetrazole substituted anthranilic acid amides as pesticides
06/24/2010CA2745297A1 Pyrimidin-2-ylamino derivatives and their use to treat inflammation
06/23/2010EP2198867A1 Pyrimidine-based compounds useful as GSK-3 inhibitors
06/23/2010EP2197874A1 Pyrazin-2-yl-pyridin-2-yl-amine and pyrazin-2-yl-pyrimidin-4-yl-amine compounds and their use
06/23/2010EP2197858A2 1,3,5-triazine-2,4,6-triamine compound or pharmaceutical acceptable salt thereof, and pharmaceutical composition comprising the same
06/23/2010EP2197551A1 Soluble guanylate cyclase activators
06/23/2010EP2197274A1 Azacytidine analogues and uses thereof
06/23/2010EP1511734B1 Compounds, compositions, and methods
06/23/2010CN1926133B Epothilone derivatives
06/23/2010CN1910176B Crystalline polymorph of a bisulfate salt of a thrombin receptor antagonist
06/23/2010CN1909907B Quinoline derivatives and use thereof for preparing mycobacterial inhibitors
06/23/2010CN1906173B Protein modifier production inhibitor
06/23/2010CN1906155B Novel hydroxamic acid ester derivant and pharmaceutical use thereof
06/23/2010CN1835751B Therapeutic agents useful for treating pain
06/23/2010CN1821236B Therapeutic heterocyclic compounds
06/23/2010CN101755013A nir-inert substrates comprising bis-oxodihydroindolylen-benzodifuranones
06/23/2010CN101754967A benzimidazole poly(adp-ribose)polymerase inhibitors
06/23/2010CN101754963A spirocyclopropyl piperidine derivatives
06/23/2010CN101754954A Nitrogen-containing heterocyclic derivative having 11 ss-hydroxysteroid dehydrogenase type I inhibitory activity
06/23/2010CN101747654A Synthesis method of benzofuran ketones purple pressure-sensitive color coupler
06/23/2010CN101747323A Method for preparing alfuzosin hydrochloride
06/22/2010US7741493 4,5-diphenyl-2-amino-4,5-dihydro-imidazole derivatives; antiinflammatory agent, neurodegenerative diseases; inflammatory bowel disease, rheumatoid arthritis and diseases associated with central nervous system, such as Alzheimer's disease
06/22/2010US7741485 3-[4-Chloro-2-fluoro-5-{[isopropyl(methyl)amino]carbonylaminosulfonyl}phenyl]-1-methyl-2,4-dioxo-6-trifluoromethyl-1,2,3,4-tetrahydropyrimidine; crop protection agent
06/22/2010US7741482 Reference standard for characterization of rosuvastatin
06/22/2010US7741345 HIV proteases as therapeutic agents for inhibition and treatment of HIV infection in humans, administered in combination with other classes of HIV therapeutic agents, especially inhibitors of HIV reverse transcriptase
06/22/2010US7741339 Fab I inhibitors
06/22/2010US7741336 N-(1-Methyl-1-phenyl-ethyl)-3-{[2-(2-oxo-2,3-dihydro-1H-indol-5-ylamino)-5-trifluoromethyl-pyrimidin-4-ylamino]-methyl}-benzenesulfonamide, useful in the treatment of breast cancer
06/22/2010US7741329 such as 1-{(S)-2-[(5-Bromo-pyrimidin-2-ylamino)-methyl]-piperidin-1-yl}-1-quinolin-2-yl-methanone, used as human orexin receptor antagonist, for the treatment of obesity and insomnia
06/22/2010US7741328 Treating inflammatory diseases such as rheumatoid arthritis, multiple sclerosis or Crohn's disease; Very Late Antigen-4 (VLA-4), also called alpha 4 beta 1 integrin; N-(sulfonamido-substituted pyrimidyl, pyridyl or pyrazyl)-L-4-(N,N-dimethylcarbamyloxy)phenylalanine compounds